Cell and Gene Regulatory
-
Reliability By Design For Single-Use Bioprocessing
9/27/2026
Success in single-use bioprocessing depends on design, supply, validation, and compliance. Learn how these factors support reliable, scalable, and resilient operations.
-
Reshoring Bioprocessing Supply Chains: The Case For Domestic Tubing
9/27/2026
Hidden costs, regulatory demands, and global disruptions challenge bioprocessing supply chains. Learn how domestic sourcing can improve reliability, quality oversight, and risk management.
-
From Proof To Promise: The Future Of Genome Editing Therapeutics
9/25/2026
CRISPR's potential depends on more than biology. Learn how advances in delivery, safety, manufacturing, and regulation are enabling clinical translation at scale.
-
Managing Risk Across The Single-Use System Lifecycle
9/24/2026
Single-use system risk extends from initial design through installation and use. See how lifecycle-wide controls can strengthen contamination prevention and support regulatory readiness.
-
How Can We Help You Achieve Drug Product Risk Control?
9/24/2026
Learn how you can strengthen contamination control by applying risk-based principles across the single-use system lifecycle, from design and validation through handling and use.
-
Single-Use Systems And Drug Product Manufacturing Challenges
9/24/2026
EU GMP Annex 1 calls for contamination control across the full manufacturing process. Learn why filter integrity testing alone is not enough and how evaluating fluid paths can strengthen quality.
-
How Does SUS Integrity Change Across The Drug Product Lifecycle?
9/24/2026
Learn how phase-appropriate risk justification, validation, documentation, and lifecycle controls can strengthen sterility assurance while reducing the potential for rework and delays.
-
The Continuing Challenge Of Drug-Induced Liver Injury
9/24/2026
Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
Annex 1 In Practice: Turning CCS Into Cleanroom Design
9/24/2026
Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.
-
CMC Considerations For CRISPR And Next-Gen Technologies
9/24/2026
CMC considerations for CRISPR and next-generation gene editing technologies are examined through the lens of LETI-101, a preclinical AAV5-delivered CRISPR candidate targeting Huntington's disease.